Moderna Inc (NAS:MRNA)
$ 141.01 8.11 (6.1%) Market Cap: 54.04 Bil Enterprise Value: 43.65 Bil PE Ratio: 0 PB Ratio: 4.21 GF Score: 68/100

Moderna Inc at Chardan Genetic Medicines Conference Transcript

Oct 08, 2019 / 03:30PM GMT
Release Date Price: $15.31 (-1.03%)
Gbolahan Amusa
Chardan Capital Markets, LLC, Research Division - Director of Research & Head of Healthcare Research

Thanks, everyone, for joining. We'll start our next fireside chat with Dr. Stephen Hoge, President of Moderna Therapeutics. Stephen, thanks for joining us and thanks for partaking in our earlier panel, the next big thing in genetic medicines.

Stephen Hoge
Moderna, Inc. - President

Thanks for having me.

Gbolahan Amusa
Chardan Capital Markets, LLC, Research Division - Director of Research & Head of Healthcare Research

So please start with just introductory comments on Moderna including recent highlights and any upcoming catalysts you'd like to emphasize.

Stephen Hoge
Moderna, Inc. - President

Sure. So briefly, Moderna, for those who don't know, we're a little bit different than a lot of the other technologies that are out here. We're focused entirely on messenger RNA as a company, non-DNA-based approaches. And we have a diversity of programs.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot